Dale J B, Chiang E Y, Liu S, Courtney H S, Hasty D L
Veterans Affairs Medical Center, Memphis, Tennessee 38104, USA.
J Clin Invest. 1999 May;103(9):1261-8. doi: 10.1172/JCI5118.
It is widely believed that the surface M protein of group A streptococci is the predominant surface protein of these organisms containing opsonic epitopes. In the present study, we identified a new surface protein, distinct from M protein, that evokes protective antibodies. A type 18 M-negative mutant was found to be both resistant to phagocytosis in human blood and virulent in mice. The wild-type strain, but not the M-negative mutant, was opsonized by antisera against purified recombinant M18 protein or a synthetic peptide copying the NH2-terminus of M18. However, antisera raised against a crude pepsin extract of the M-negative mutant opsonized both strains, indicating the presence of a protective antigen in addition to type 18 M protein. This antiserum was used to identify and purify a 24-kDa protein fragment (Spa, streptococcal protective antigen) that evoked antibodies that opsonized the M18 parent and the M-negative mutant. The results of passive mouse protection tests confirmed the presence of protective epitopes within Spa. The deduced amino acid sequence of a 636-bp 5' fragment of the spa18 gene showed no homology with sequences in GenBank. These studies reveal the presence of a new protective antigen of certain strains of group A streptococci that may prove to be an important component of vaccines to prevent streptococcal infections.
人们普遍认为,A 组链球菌的表面 M 蛋白是这些含有调理素表位的微生物的主要表面蛋白。在本研究中,我们鉴定出一种不同于 M 蛋白的新表面蛋白,它能引发保护性抗体。发现一株 18 型 M 阴性突变体对人血中的吞噬作用具有抗性,并且在小鼠中具有致病性。野生型菌株可被抗纯化重组 M18 蛋白或复制 M18 NH2 末端的合成肽的抗血清调理,但 M 阴性突变体则不能。然而,针对 M 阴性突变体的粗胃蛋白酶提取物产生的抗血清可调理这两种菌株,这表明除了 18 型 M 蛋白外还存在一种保护性抗原。该抗血清用于鉴定和纯化一个 24 kDa 的蛋白片段(Spa,链球菌保护性抗原),该片段引发的抗体可调理 M18 亲本菌株和 M 阴性突变体。被动小鼠保护试验结果证实 Spa 内存在保护性表位。spa18 基因 636 bp 5' 片段的推导氨基酸序列与 GenBank 中的序列无同源性。这些研究揭示了 A 组链球菌某些菌株中存在一种新的保护性抗原,这可能被证明是预防链球菌感染疫苗的重要组成部分。